Health Care · Electromedical & Electrotherapeutic Apparatus · Nasdaq · CIK 1560258 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $10.81 · Day +5.26% · Mkt cap $93M · 1Y +117.5% · Off 52W high −1.1% · Vol (1Y) 87.2% Price2023-08-21 → 2026-08-19 ECOR close: $4.7 on 2023-08-21 to $10.8 on 2026-08-19. Split-adj closes · 240 of 2,047 · price returnⓘ At a glance | Short interest3.9% of sh out | | Days to cover7.6d | | 13F net flow (QoQ)−0.43% | | Top-10 13F concentration86.0% | | Next report (est.)2026-11-05 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$37.0M | | Earnings (TTM)-$14.8M | | Net margin−43.6% | | ROIC−1217.4% | | Sales growth 3Y55.1% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+141.0% | | 1Y+117.5% | | 3Y+130.5% | | 5Y−23.7% | | Since incept. (ann.)−33.4% |
Total return · from 2018-06-22ⓘ Risk | Ann. volatility (1Y)87.2% | | Ann. volatility (3Y)80.1% | | Sharpe (1Y)1.23 | | Sharpe (3Y)0.76 | | Max drawdown (1Y)−44.2% | | Max drawdown (3Y)−77.7% | | Beta (3Y vs SPY)0.88 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 202,644 | $1M | 2.51% | new | | Balyasny Asset Management L.P. | 116,463 | $702,272 | 1.44% | new | | GEODE CAPITAL MANAGEMENT, LLC | 78,083 | $470,936 | 0.97% | +11.2% | | Jaffetilchin Investment Partners, LLC | 58,198 | $350,934 | 0.72% | +11.1% | | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 46,620 | $307,692 | 0.58% | −47.5% | | Wealthspire Advisors, LLC | 47,498 | $286,413 | 0.59% | +0.0% | | RENAISSANCE TECHNOLOGIES LLC | 44,409 | $267,786 | 0.55% | −18.5% | | VANGUARD FIDUCIARY TRUST CO | 38,528 | $232,324 | 0.48% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-06 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-06 | −$0.33 | — | $9.4M | +28.0% | | 2026-03-31 | 2026-05-06 | −$0.59 | — | $9.6M | +42.6% | | 2025-12-31 | 2026-03-19 | — | — | $9.2M | +31.2% | | 2025-09-30 | 2025-11-05 | −$0.40 | — | $8.7M | +32.6% |
As-reported XBRL · next 2026-11-05 est.ⓘ Segment mixFY2025 (ended Dec 2025) Bioelectronic Innovations 100% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
